Influence of Co-Morbid Hypertension and Diabetes Mellitus on Electrocardiographic Abnormalities in Stroke Cases

References

[1] World Health Organization. Cerebrovascular Disorder Geneva: World Health Organization.1978.24-6

[2] Boutayeb A and Boutayeb S. The burden of non-communicable disease in developing countries. Int. J. Equity Health. 2005; 4: 2-6.

[3] Ellekjaer H, Holmen J, Indredavik B, et al. Epidemiology of stroke in Innherred, Norway, 1994 to 1996: Incidence and a 30 – Day case fatality rate.Stroke .1997; 28: 2180 -2184.

[4] Kocan M J. Cerebrovascular effects of acute stroke. Prog Cardiovascular Nurs.1999; 1:61—7.

[5] Goldstein D S. The electrocardiogram in stroke: relationship to pathophysiological type and comparism with prior tracings. Stroke. 1979; 10: 253-9.

[6] Familoni O.B. The pattern and prognostic features of QT intervals and dispersion in patients with acute ischaemic stroke. J Natl Med. Assoc. 2006; 98: 1758-62.

[7] Tokgozoglu S.L, Batur M.K, Topcuoglu M.A, et al. Effects of Stroke localization on Cardiac Autonomic Balance and Sudden Death. Stroke. 1999; 30:1307-11.

[8] World Health Organization. The World Health Report 2004. Annex Table 2: Deaths by cause, sex and mortality stratum in WHO regions, estimates 2002.Geneva. World Health Organization.2004.

[9] Donnan G A, fisher M, Macleod M, et al. Stroke. Lancet. 2008; 371: 1612 -15.

[10] Go A.S, Mozaffarian D, Roger V .L et al. Heart and stroke statistics 2013update report from the American Heart Association. Circulation. 2013; 2: 241-6.

[11] WHO. The top 10 causes of death. Geneva. World Health Organization. 2017. Available from www.who.int/en/news-room/factsheets/detail/the-top-10-causes-of-death (Accessed on 16th May 2018).

[12] Senelick R, Rossi C, Peter W, et al.Living with stroke: A Guide for facilities. Chicago. Contemporary books. 1994.10-6

[13] National Institute of Neurological Disorders and Stroke (NINDS).’Stroke Hope Through Research’. National Institute of Health.1999.112-5

[14] Bamford J. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet.1991; 337:1521 – 6.

[15] Bamford J. M. ’The role of the clinical examination in the subclassification of stroke’. Cerebrovas. Dis.2000; 10:2 – 4

[16] Wang J. ’Preclinical and clinical research on inflammation after intracerebral haemorrhage’. Prog. Neurobiol. 2010; 92: 463–77.

[17] Adeloye D. An estimate of the prevalence of hypertension in Nigeria: a systematic review and meta-analysis. J. Hypertension. 2015; 2: 260 – 262.

[18] Oppenheimer S M, Hachinski V C. The cardiac consequence of stroke. Neurol Clin.1992;10 :167- 76.

[19] Oppenheimer S M. Lateral hypothalamic area neurotransmission and neuromodulation of the specific cardiac effects of insular cortex stimulation. Brain Res.1992; 581:133- 142.

[20] Ogun S A. Comparism of Siriraj Stroke Score and the WHO criteria in the clinical classification of stroke subtypes. Afr J Med Sci.2002; 3:13- 16.

[21] Imariagbe F.A, Akemokwe F.M, Unuigbe E.I, et al. Clinical diagnosis of intracerebral haemorrhage : validation of a simple scoring tool in West Africans. West Afr J. Med.2012; 31:172-5.

@article{1703315,
      author = {Dr. Osarenkhoe Osaretin John},
      title = {Influence of Co-Morbid Hypertension and Diabetes Mellitus on Electrocardiographic Abnormalities in Stroke Cases},
      journal = {Iconic Research And Engineering Journals},
      year = {2022},
      volume = {5},
      number = {9},
      pages = {550-555},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1703315.pdf},
      abstract = {Stroke or cerebrovascular accident according to World Health Organization (WHO) is a focal or global neurological deficit of vascular origin lasting more than twenty-four hours or resulting in death before twenty-four hours. In sub-Saharan Africa as well as around the globe, stroke is the second leading cause of death worldwide after ischaemic heart disease with the victims mainly in the productive age ranges. 
Notably, strokes are preceded by modifiable risk factors such as hypertension, diabetes mellitus, obesity, smoking and alcohol ingestion. The use of electrocardiography (ECG) in addition to controlling these risk factors would reduce the occurrence, morbidity and mortality of stroke in at-risk patients as ECG is both a preventive and prognostic tool. The knowledge of data regarding abnormalities present in this group of patients will offer knowledge that will enhance physicians? patient management and provide data for future research.},
      month = {March},
  }